Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor

Gozdasoglu Kucukalioglu, Elif

Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor

Sevgi GÖZDAŞOĞLU (Boş)

Turkish Journal of Hematology

0 0

Yıl: 2013 Cilt: 30 Sayı: 1 Sayfa Aralığı: 96 - 97 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor

Öz:

Anahtar Kelime:

Konular: Hematoloji

Kallikrein inhibitörü ile tedavi edilen otoeritrosit sensitizasyon sendromu

Öz:

Anahtar Kelime:

Konular: Hematoloji

Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık

1. Okur M, Turan H, Özkan A, Güneş C, Kocabay K. An extremely rare cause of bruising in children: autoerythrocyte sensitization syndrome. Turk J Hematol 2012;29:201-203.
2. Karaca M, Akoğuz Ö, Bölükoğlu B. Otoeritrosit hassasiyeti sendromu. Türk Hematoloji Cemiyeti VII Kongresi. 13-15 April 1972, Ankara. Hematoloji III, s. 111.
3. Karaca M, Akoğuz Ö, Bölükoğlu B. Autoerythrocyte sensitization syndrome. New Istanbul Contrib Clin Sci 1973;10:222-229.
4. Çavdar AO, Gözdaşoğlu S. Gardner-Diamond sendromu. A Ü Tıp Fac Mec 1974;2:344-351.
5. Gottlieb AJ. Autoerythrocyte and DNA sensitivity. In: William JW, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 4th ed. McGraw-Hill, New York, 1991, 1441-1444.
6. Miranda JV. Gardner-Diamond’s syndrome: literature review. Int J Collab Res Int Med Pub Health, at www.readperiodicals .com/2674727381, 2012
7. Agle DP, Ratnoff OD. Purpura as a psychosomatic entity. Arch Int Med 1962;109:685-694.
8. Groch GS, Finch SC, Rogoway W, Fischer DS. Studies in the pathogenesis of autoerythrocyte sensitization syndrome. Blood 1966;28:19-33.
9. Leiba H, Almog C, Kaufman S, Edery H. Possible role of bradykinin in a patient with recurrent ecchymoses (DNA sensitization). Isr J Med Sci 1972;8:67-74.
10. Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol 2001;28:1060-1065.
11. Gözdaşoğlu S, Türker K, Kandilci U, Kervancıoğlu C, Uzunalimoğlu Ö. Oto eritrositduyarlık sendromu ve kallikrein-inhibitörü (Trasylol R) ile tedavi. A Ü Tıp Fac Mec 1980;43:427-230.

APA	Gozdasoglu Kucukalioglu E (2013). Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. , 96 - 97.
Chicago	Gozdasoglu Kucukalioglu Elif Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. (2013): 96 - 97.
MLA	Gozdasoglu Kucukalioglu Elif Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. , 2013, ss.96 - 97.
AMA	Gozdasoglu Kucukalioglu E Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. . 2013; 96 - 97.
Vancouver	Gozdasoglu Kucukalioglu E Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. . 2013; 96 - 97.
IEEE	Gozdasoglu Kucukalioglu E "Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor." , ss.96 - 97, 2013.
ISNAD	Gozdasoglu Kucukalioglu, Elif. "Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor". (2013), 96-97.

APA	Gozdasoglu Kucukalioglu E (2013). Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. Turkish Journal of Hematology, 30(1), 96 - 97.
Chicago	Gozdasoglu Kucukalioglu Elif Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. Turkish Journal of Hematology 30, no.1 (2013): 96 - 97.
MLA	Gozdasoglu Kucukalioglu Elif Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. Turkish Journal of Hematology, vol.30, no.1, 2013, ss.96 - 97.
AMA	Gozdasoglu Kucukalioglu E Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. Turkish Journal of Hematology. 2013; 30(1): 96 - 97.
Vancouver	Gozdasoglu Kucukalioglu E Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor. Turkish Journal of Hematology. 2013; 30(1): 96 - 97.
IEEE	Gozdasoglu Kucukalioglu E "Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor." Turkish Journal of Hematology, 30, ss.96 - 97, 2013.
ISNAD	Gozdasoglu Kucukalioglu, Elif. "Autoerythrocyte sensitization syndrome treated with kallikrein inhibitor". Turkish Journal of Hematology 30/1 (2013), 96-97.